WDHA (watery diarrhea, hypokalemia, and achlorhydria) syndrome is an u
nusual paraneoplastic condition caused by excess vasoactive intestinal
polypeptide (VIP) secreted by certain tumors. The onset of the syndro
me is insidious, and diagnosis is usually delayed by months to years.
Morbidity and mortality from untreated WDHA syndrome are related to lo
ng-standing dehydration and electrolyte and acid-base disturbances res
ulting in chronic renal failure. Diagnosis requires documentation of l
arge volumes of secretory diarrhea, elevated serum VIP levels, and loc
alization of the VIP-secreting tumor. Treatment includes correction of
volume, electrolyte, and metabolic abnormalities, pharmacotherapy to
decrease gastrointestinal secretion and increase absorption, and ultim
ately surgical resection or debulking of the vipoma.